Total Payments
$2,047
2024 Payments
$595.51
Companies
30
Transactions
116
Medicare Patients
5,762
Medicare Billing
$581,557
Payment Breakdown by Category
Food & Beverage$2,047 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,047 | 116 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $464.78 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $203.20 | 14 | $0 (2023) |
| Corcept Therapeutics | $145.37 | 9 | $0 (2024) |
| EISAI INC. | $118.72 | 7 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $107.09 | 7 | $0 (2024) |
| PFIZER INC. | $105.59 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $98.05 | 6 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $91.32 | 7 | $0 (2021) |
| GlaxoSmithKline, LLC. | $79.28 | 4 | $0 (2024) |
| Purdue Pharma L.P. | $60.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $595.51 | 27 | ABBVIE INC. ($372.98) |
| 2023 | $228.03 | 13 | Merck Sharp & Dohme LLC ($57.13) |
| 2022 | $364.07 | 22 | Merck Sharp & Dohme LLC ($80.68) |
| 2021 | $197.96 | 14 | Eisai Inc. ($69.01) |
| 2020 | $113.96 | 8 | Nevro Corp. ($18.66) |
| 2019 | $295.00 | 21 | Novartis Pharmaceuticals Corporation ($63.83) |
| 2018 | $166.74 | 8 | Philips Electronics North America Corporation ($55.71) |
| 2017 | $85.85 | 3 | Purdue Pharma L.P. ($60.37) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/03/2024 | Avanos Medical | TRIVISC SODIUM HYALURONATE (Device) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Zimmer Biomet Holdings, Inc. | VISCO-3 sodium hyaluronate (Device), Gel-One Cross-linked Hyaluronate, Gel-One Cross-linked Hyaluronate | Food and Beverage | Cash or cash equivalent | $44.93 | General |
| Category: Knees | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Cardio-renal | ||||||
| 07/31/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Endocrinology | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.98 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Endocrinology | ||||||
| 05/22/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $27.76 | General |
| 05/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: NEUROSCIENCE | ||||||
| 04/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 04/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: Endocrinology | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.59 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,222 | 1,938 | $367,372 | $128,394 |
| 2022 | 30 | 1,415 | 1,962 | $361,514 | $135,782 |
| 2021 | 35 | 1,871 | 2,719 | $431,450 | $165,861 |
| 2020 | 31 | 1,254 | 2,278 | $296,019 | $151,521 |
Total Patients
5,762
Total Services
8,897
Medicare Billing
$581,557
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 141 | 468 | $115,194 | $40,512 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 116 | 275 | $94,760 | $32,269 | 34.1% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 86 | 99 | $24,017 | $7,257 | 30.2% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 103 | 118 | $18,342 | $6,367 | 34.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 102 | 111 | $18,095 | $6,254 | 34.6% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 86 | 99 | $16,592 | $5,521 | 33.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 57 | $11,264 | $5,113 | 45.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 39 | $14,938 | $5,099 | 34.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $9,290 | $2,888 | 31.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 28 | 29 | $5,870 | $2,491 | 42.4% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 36 | 37 | $6,032 | $2,045 | 33.9% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 33 | 74 | $3,700 | $1,698 | 45.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 97 | 97 | $3,358 | $1,617 | 48.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 30 | 33 | $3,276 | $1,141 | 34.8% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 13 | 13 | $3,320 | $1,033 | 31.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 20 | $2,425 | $1,022 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $2,596 | $1,002 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 12 | $3,833 | $921.30 | 24.0% |
| G2011 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes | Office | 2023 | 75 | 75 | $2,454 | $911.77 | 37.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 39 | 39 | $1,981 | $910.10 | 45.9% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 33 | 33 | $2,277 | $801.56 | 35.2% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 28 | 28 | $1,422 | $679.00 | 47.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 18 | 19 | $1,456 | $543.96 | 37.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 24 | 25 | $375.00 | $210.00 | 56.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 101 | $505.00 | $87.13 | 17.3% |
About Dr. Brian Bluth, MD
Dr. Brian Bluth, MD is a Family Medicine healthcare provider based in Weatherford, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215043435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Bluth, MD has received a total of $2,047 in payments from pharmaceutical and medical device companies, with $595.51 received in 2024. These payments were reported across 116 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,047).
As a Medicare-enrolled provider, Bluth has provided services to 5,762 Medicare beneficiaries, totaling 8,897 services with total Medicare billing of $581,557. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Weatherford, OK
- Active Since 08/21/2006
- Last Updated 11/19/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215043435
Products in Payments
- VRAYLAR (Drug) $431.83
- BELSOMRA (Drug) $165.59
- Korlym (Drug) $145.37
- Dayvigo (Drug) $118.72
- Kerendia (Drug) $107.09
- ENTRESTO (Drug) $98.05
- HYSINGLA ER (Drug) $60.37
- IGT_D Peripheral (Device) $55.71
- Puraply (Medical Supply) $55.49
- SPIRIVA RESPIMAT (Drug) $53.02
- VISCO-3 sodium hyaluronate (Device) $44.93
- LYRICA (Drug) $44.49
- GLASSIA (Biological) $40.84
- FARXIGA (Drug) $40.09
- CHANTIX (Drug) $35.81
- NEXPLANON (Drug) $35.54
- ANORO (Drug) $33.17
- QULIPTA (Drug) $32.95
- Ozempic (Drug) $28.99
- TRULICITY (Drug) $26.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weatherford
Adam Khadbai, M.d, M.D
Family Medicine — Payments: $18,816
Family Medicine $18,816
Rupa Pachigolla, M.d, M.D
Family Medicine — Payments: $9,183
Family Medicine $9,183
Steven Melcher, M.d, M.D
Family Medicine — Payments: $5,814
Family Medicine $5,814
Robert Miller, Md, MD
Family Medicine — Payments: $5,529
Family Medicine $5,529
Dr. Blake Badgett, M.d, M.D
Family Medicine — Payments: $4,884
Family Medicine $4,884
Miguel Gutierrez, Md, MD
Family Medicine — Payments: $4,767
Family Medicine $4,767